LENZ Therapeutics LENZ
NASDAQ LENZ
$4.75 +0.09 (+1.93%)
As of: Aug 21, 2026 · 10:31 AM EDT

LENZ Therapeutics (LENZ) Net Margin (QoQ) (2025 - 2026)

LENZ Therapeutics (LENZ) Net Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.00 Bn 132.14 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.31 Bn 78.32 Bn 3.93 Bn
3 Argenx Se 65.24 Bn 60.06 Bn 1.37 Bn
4 Moderna 62.41 Bn 57.27 Bn 52.00 Mn
5 BeOne Medicines 42.25 Bn 37.15 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.18 Bn 27.88 Bn 992.69 Mn
7 BioNTech SE 28.93 Bn 10.54 Bn 668.28 Mn
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
9 Royalty Pharma 27.28 Bn 26.44 Bn -
10 LENZ Therapeutics 149.03 Mn 149.03 Mn 5.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 181,393.00
Mar 31, 2026 -250,742.00
Dec 31, 2025 42,077.00
Sep 30, 2025 16,464.00